Tcw Group Inc Novartis Ag Transaction History

Tcw Group Inc

  • $11.2 Billion
  • Q3 2024

A detailed history of Tcw Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Tcw Group Inc holds 73,745 shares of NVS stock, worth $7.69 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
73,745
Previous 73,745 -0.0%
Holding current value
$7.69 Million
Previous $8.48 Million -0.0%
% of portfolio
0.08%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$106.13 - $120.89 $25,365 - $28,892
-239 Reduced 0.32%
73,745 $8.48 Million
Q2 2024

Jul 18, 2024
SELL
$92.57 - $107.37 $91,181 - $105,759
-985 Reduced 1.31%
73,984 $7.88 Million
Q1 2024

May 09, 2024
BUY
$95.27 - $108.47 $4,572 - $5,206
48 Added 0.06%
74,969 $7.25 Million
Q4 2023

Feb 09, 2024
BUY
$92.27 - $101.54 $130,377 - $143,476
1,413 Added 1.92%
74,921 $7.56 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $259,086 - $287,530
-2,735 Reduced 3.59%
73,508 $7.49 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $1,572 - $1,783
-17 Reduced 0.02%
76,243 $7.69 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $326,442 - $378,571
4,079 Added 5.65%
76,260 $7.02 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $1,662 - $2,035
22 Added 0.03%
72,181 $6.55 Million
Q3 2022

Oct 27, 2022
BUY
$74.61 - $87.26 $8,953 - $10,471
120 Added 0.17%
72,159 $5.49 Million
Q2 2022

Jul 19, 2022
SELL
$80.52 - $93.75 $63,691 - $74,156
-791 Reduced 1.09%
72,039 $6.09 Million
Q1 2022

Apr 19, 2022
SELL
$80.11 - $90.62 $3,044 - $3,443
-38 Reduced 0.05%
72,830 $6.39 Million
Q4 2021

Jan 26, 2022
SELL
$79.7 - $88.13 $398 - $440
-5 Reduced 0.01%
72,868 $6.37 Million
Q3 2021

Oct 26, 2021
SELL
$81.78 - $95.14 $14,393 - $16,744
-176 Reduced 0.24%
72,873 $5.96 Million
Q2 2021

Jul 23, 2021
SELL
$85.24 - $94.15 $824,270 - $910,430
-9,670 Reduced 11.69%
73,049 $6.66 Million
Q1 2021

May 05, 2021
SELL
$83.5 - $98.47 $21,793 - $25,700
-261 Reduced 0.31%
82,719 $7.07 Million
Q4 2020

Feb 02, 2021
SELL
$78.07 - $94.43 $1.48 Million - $1.79 Million
-18,922 Reduced 18.57%
82,980 $7.84 Million
Q3 2020

Oct 30, 2020
BUY
$82.14 - $91.0 $15,195 - $16,835
185 Added 0.18%
101,902 $8.86 Million
Q2 2020

Aug 05, 2020
SELL
$80.93 - $91.1 $574,926 - $647,174
-7,104 Reduced 6.53%
101,717 $8.88 Million
Q1 2020

May 05, 2020
BUY
$70.67 - $99.01 $5,370 - $7,524
76 Added 0.07%
108,821 $8.97 Million
Q4 2019

Feb 10, 2020
BUY
$84.35 - $95.37 $306,274 - $346,288
3,631 Added 3.45%
108,745 $10.3 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $21,727 - $23,942
254 Added 0.24%
105,114 $9.13 Million
Q2 2019

Aug 07, 2019
SELL
$75.4 - $92.8 $5.01 Million - $6.17 Million
-66,493 Reduced 38.8%
104,860 $9.57 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $2.74 Million - $3.13 Million
-36,336 Reduced 17.5%
171,353 $16.5 Million
Q4 2018

Feb 11, 2019
SELL
$73.66 - $82.02 $77,711 - $86,531
-1,055 Reduced 0.51%
207,689 $17.8 Million
Q3 2018

Oct 30, 2018
BUY
$66.94 - $77.43 $3.31 Million - $3.82 Million
49,388 Added 30.99%
208,744 $18 Million
Q2 2018

Aug 02, 2018
BUY
$64.91 - $73.36 $1.99 Million - $2.25 Million
30,625 Added 23.79%
159,356 $12 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $972,719 - $1.16 Million
13,819 Added 12.03%
128,731 $10.4 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $5.25 Million - $5.64 Million
72,586 Added 171.49%
114,912 $9.65 Million
Q3 2017

Nov 06, 2017
SELL
$74.14 - $77.27 $204,255 - $212,878
-2,755 Reduced 6.11%
42,326 $3.63 Million
Q2 2017

Aug 11, 2017
BUY
N/A
45,081
45,081 $3.76 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email